Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Estimates and Forecast Timeline
1.2 Objectives
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 Research Methodology
1.4 Information Procurement
1.5 Market Specific Research Models
1.5.1 Consensus-Based Estimates & Forecasting
1.5.2 Model 1: Commodity Flow Analysis
1.5.3 Model 2: Demand Based Market Sizing Framework
1.5.4 Model 3: Primary Research Methodology
1.5.5 Model 4: Internal Database
1.5.6 Model 5: CAGR Calculation and Forecast Modeling
1.6 List of Secondary Sources
1.7 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Application Segment Outlook
2.3 Disease Area Segment Outlook
2.4 Competitive Landscape
2.5 Key Technology Trends
Chapter 3 Market Variables, Trends and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.1.2.1 AI in Cardiology Market
3.1.2.2 AI in Medical Imaging Market
3.1.2.3 AI in Endoscopy Market
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Prevalence of Diseases and Growing Healthcare Needs
3.2.1.2 Growing Adoption of AI Automation in Healthcare Facilities
3.2.1.2.1 Increasing Adoption of AI-Enabled Diagnostic Software
3.2.1.2.2 Government Budget Allocation for AI in Healthcare
3.2.1.3 Supportive and Structured Regulatory Framework
3.2.1.4 Technological Innovations in the AI-Enabled Medical Devices
3.2.2 Market Restraint Analysis
3.2.2.1 Limited Reimbursement for AI-Based Diagnostics
3.2.2.2 Cybersecurity Concerns are Slowing Cloud-Based AI Adoption
3.2.3 Market Opportunity Analysis
3.2.4 Market Challenge Analysis
3.2.3.1 Overseas Manufacturers Depend on Local Partners
3.3 Technology Trends
3.3.1 Integration of AI Into Medical Equipment
3.3.2 AI-Based Diagnostic Support
3.3.3 AI-Enabled Patient Monitoring
3.3.4 Software as a Medical Device (SaMD)
3.3.5 Integration of AI with Hospital Workflows
3.3.6 Emerging AI-enabled Diagnostic Devices
3.4 Regulatory & Market Entry Overview
3.4.1 Regulatory Considerations for AI-Enabled Medical Devices
3.4.2 AI/Samd Approval Considerations
3.4.3 Overseas Manufacturer Entry Considerations
3.4.4 Local Partnership/Distributor Considerations
3.5 Japan Market Opportunity / Gap Assessment
3.5.1 Technologies Already Well Penetrated
3.5.2 Emerging Technology Areas
3.5.3 Areas with Strong Incumbent Competition
3.5.4 Potential Technology White Spaces
3.6 Industry Analysis Tools
3.6.1 Porter’s Five Forces Analysis
3.6.2 PESTLE Analysis
Chapter 4 Japan AI-Enabled Medical Devices Market: Application / Technology Estimates & Trend Analysis
4.1 Segment Definition
4.2 Japan AI-Enabled Medical Devices Market: Application / Technology Segment Dashboard
4.3 Application / Technology Movement & Market Share Analysis, 2025 & 2033
4.4 Japan AI-Enabled Medical Devices Market Size Estimates & Forecast, Application/Technology, 2021 - 2033 (USD Million)
4.4.1 Japan AI-Enabled Medical Devices Market Size Estimates & Forecast, AI Medical Imaging, 2021 - 2033 (USD Million)
4.4.1.1 Japan AI-Enabled Medical Devices Market Size Estimates & Forecast, AI Cardiology & Cardiac Diagnostics, 2021 - 2033 (USD Million)
4.4.1.2 Japan AI-Enabled Medical Devices Market Size Estimates & Forecast, AI Neurology & Neurological Diagnostics, 2021 - 2033 (USD Million)
4.4.2 AI Medical Imaging
4.4.2.1 AI Medical Imaging Market, 2021 - 2033 (USD Million)
4.4.2.2 Radiology AI
4.4.2.2.1 Radiology AI Market, 2021 - 2033 (USD Million)
4.4.2.3 AI-Assisted Image Interpretation
4.4.2.3.1 AI-Assisted Image Interpretation Market, 2021 - 2033 (USD Million)
4.4.2.4 Computer-Aided Detection/Diagnosis
4.4.2.4.1 Computer-Aided Detection/Diagnosis Market, 2021 - 2033 (USD Million)
4.4.2.5 Other Imaging AI
4.4.2.5.1 Other Imaging AI Market, 2021 - 2033 (USD Million)
4.4.3 AI-Enabled Endoscopy
4.4.3.1 AI-Enabled Endoscopy Market, 2021 - 2033 (USD Million)
4.4.4 AI Cardiology & Cardiac Diagnostics
4.4.4.1 AI Cardiology & Cardiac Diagnostics Market, 2021 - 2033 (USD Million)
4.4.4.2 ECG Analysis
4.4.4.2.1 ECG Analysis Market, 2021 - 2033 (USD Million)
4.4.4.3 Arrhythmia Detection
4.4.4.3.1 Arrhythmia Detection Market, 2021 - 2033 (USD Million)
4.4.4.4 Other AI-Enabled Cardiac Diagnostics
4.4.4.4.1 Other AI-Enabled Cardiac Diagnostics Market, 2021 - 2033 (USD Million)
4.4.5 AI Neurology & Neurological Diagnostics
4.4.5.1 AI Neurology & Neurological Diagnostics Market, 2021 - 2033 (USD Million)
4.4.5.2 EEG Analysis
4.4.5.2.1 EEG Analysis Market, 2021 - 2033 (USD Million)
4.4.5.3 Neurological
4.4.5.3.1 Neurological Market, 2021 - 2033 (USD Million)
4.4.5.4 Other AI-Enabled Neurological Devices
4.4.5.4.1 Other AI-Enabled Neurological Devices Market, 2021 - 2033 (USD Million)
4.4.6 AI Patient Monitoring & Physiological Monitoring
4.4.6.1 AI Patient Monitoring & Physiological Monitoring Market, 2021 - 2033 (USD Million)
4.4.7 Other AI-Enabled Medical Devices
4.4.7.1 Other AI-Enabled Medical Devices Market, 2021 - 2033 (USD Million)
Chapter 5 Japan AI-Enabled Medical Devices Market: Disease Area Estimates & Trend Analysis
5.1 Segment Definition
5.2 Japan AI-Enabled Medical Devices Market: Disease Area Segment Dashboard
5.3 Disease Area Movement & Market Share Analysis, 2025 & 2033
5.4 Japan AI-Enabled Medical Devices Market Size Estimates & Forecast, Disease Area, 2021 - 2033 (USD Million)
5.4.1 Oncology
5.4.1.1 Oncology Market, 2021 - 2033 (USD Million)
5.4.2 Cardiovascular Diseases
5.4.2.1 Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
5.4.3 Neurological Disorders
5.4.3.1 Neurological Disorders Market, 2021 - 2033 (USD Million)
5.4.4 Gastrointestinal Disorders
5.4.4.1 Gastrointestinal Disorders Market, 2021 - 2033 (USD Million)
5.4.5 Respiratory and Pulmonary Diseases
5.4.5.1 Respiratory and Pulmonary Diseases Market, 2021 - 2033 (USD Million)
5.4.6 Musculoskeletal and Orthopedic Conditions
5.4.6.1 Musculoskeletal and Orthopedic Conditions Market, 2021 - 2033 (USD Million)
5.4.7 Other Disease Areas
5.4.7.1 Other Disease Areas Market, 2021 - 2033 (USD Million)
Chapter 6 Japan AI-Enabled Medical Devices Market: Competitive Landscape
6.1 Key Company Categorization
6.2 Company Market Positioning, 2025
6.3 Existing AI Medical Device Companies in Japan
6.3.1 Cybernet Systems Corporation
6.3.1.1 Company Overview
6.3.1.2 Financial Performance
6.3.1.3 Product Benchmarking
6.3.1.4 Strategic Initiatives
6.3.2 NEC Corporation
6.3.2.1 Company Overview
6.3.2.2 Financial Performance
6.3.2.3 Product Benchmarking
6.3.2.4 Strategic Initiatives
6.3.3 Fujifilm Corporation
6.3.3.1 Company Overview
6.3.3.2 Financial Performance
6.3.3.3 Product Benchmarking
6.3.3.4 Strategic Initiatives
6.3.4 LPIXEL Inc.
6.3.4.1 Company Overview
6.3.4.2 Financial Performance
6.3.4.3 Product Benchmarking
6.3.4.4 Strategic Initiatives
6.3.5 AI Medical Service Inc.
6.3.5.1 Company Overview
6.3.5.2 Financial Performance
6.3.5.3 Product Benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 Canon Medical Systems Corporation
6.3.6.1 Company Overview
6.3.6.2 Financial Performance
6.3.6.3 Product Benchmarking
6.3.6.4 Strategic Initiatives
6.3.7 Konica Minolta, Inc.
6.3.7.1 Company Overview
6.3.7.2 Financial Performance
6.3.7.3 Product Benchmarking
6.3.7.4 Strategic Initiatives
6.3.8 DoctorNet Co., Ltd.
6.3.8.1 Company Overview
6.3.8.2 Financial Performance
6.3.8.3 Product Benchmarking
6.3.8.4 Strategic Initiatives
6.3.9 Cardio Intelligence Inc.
6.3.9.1 Company Overview
6.3.9.2 Financial Performance
6.3.9.3 Product Benchmarking
6.3.9.4 Strategic Initiatives
6.3.10 Aillis Inc.
6.3.10.1 Company Overview
6.3.10.2 Financial Performance
6.3.10.3 Product Benchmarking
6.3.10.4 Strategic Initiatives
6.3.11 Fujitsu Limited
6.3.11.1 Company Overview
6.3.11.2 Financial Performance
6.3.11.3 Product Benchmarking
6.3.11.4 Strategic Initiatives
6.4 Additional Companies List
Chapter 7 Japan AI-Enabled Medical Devices Market: Overseas Technology & Inbound Opportunity Assessment
7.1 Overseas Companies Already Entering / Expanding in Japan
7.1.1 Strategic Initiatives
7.1.2 Mergers & Acquisitions
7.1.3 Product Launches and Approvals
7.1.4 Partnerships & Collaborations and Agreements
7.1.5 Regional Expansion
7.1.6 OTHERS
7.2 Overseas Companies with Limited / No Significant Japan Presence
7.3 Potential Inbound Opportunity Shortlist
Chapter 8 Japan AI-Enabled Medical Devices Market: Market Entry Assessment
8.1 Potential Entry Routes into Japan
8.1.1 Direct Market Entry
8.1.2 Strategic Partnership
8.1.3 Licensing
8.1.4 OEM Partnership
8.2 Examples of Overseas Companies Entering Japan
8.3 Key Entry Considerations
8.4 Potential Local Partnership Ecosystem
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Selected AI-enabled products available/approved in Japan
Table 4 Japan AI-enabled medical devices market, application/technology, 2021 - 2033 (USD Million)
Table 5 Japan AI-enabled medical devices market, AI medical imaging, 2021 - 2033 (USD Million)
Table 6 Japan AI-enabled medical devices market, AI cardiology & cardiac diagnostics, 2021 - 2033 (USD Million)
Table 7 Japan AI-enabled medical devices market, AI neurology & neurological diagnostics, 2021 - 2033 (USD Million)
Table 8 Examples of PMDA-approved AI-based CAD programs in Japan, 2025
Table 9 List of approved AI-based endoscopic systems in Japan
Table 10 Japan AI-enabled medical devices market, region, 2021 - 2033 (USD Million)
Table 11 Projected cancer incidence in Japan, 2025
Table 12 Evaluation framework and weighting
Table 13 Shortlisted overseas technologies and addressed Japan segment
Table 14 Scoring rationale by technology
Table 15 Tier 1 - Priority inbound opportunities
Table 16 Tier 2 - Selective and Tier 3 - Watch opportunities
Table 17 Comparison of entry routes
Table 18 Overseas AI-enabled medical device entries into Japan
Table 19 Key considerations for overseas AI-enabled medical device entrants
Table 20 Local partner categories
Table 21 Entry route and partner fit for shortlisted technologies
List of Figures
Figure 1 Japan AI-enabled medical devices market segmentation
Figure 2 Commodity flow analysis
Figure 3 Market snapshot
Figure 4 Application segment outlook
Figure 5 Disease area segment outlook
Figure 6 Competitive landscape
Figure 7 Japan AI-enabled medical devices market dynamics
Figure 8 Market driver relevance analysis (Current & future impact)
Figure 9 Domain distribution of 51 AI designated program medical devices
Figure 10 Market restraint analysis (Current & future impact)
Figure 11 Japan AI-enabled medical devices market: Porter’s five forces analysis
Figure 12 Japan AI-enabled medical devices market: PESTLE analysis
Figure 13 Japan AI-enabled medical devices market: Application / technology segment dashboard
Figure 14 Japan AI-enabled medical devices market by application / technology: Market share analysis, 2025 & 2033
Figure 15 AI medical imaging market, 2021 - 2033 (USD Million)
Figure 16 Distribution of AI-enabled radiology SaMD products in Japan by imaging modality, 2024 (Number of products)
Figure 17 Radiology AI market 2021 - 2033 (USD Million)
Figure 18 AI-assisted image interpretation market 2021 - 2033 (USD Million)
Figure 19 Computer-aided detection/diagnosis market 2021 - 2033 (USD Million)
Figure 20 Other imaging AI market 2021 - 2033 (USD Million)
Figure 21 AI-enabled endoscopy market, 2021 - 2033 (USD Million)
Figure 22 AI cardiology & cardiac diagnostics market, 2021 - 2033 (USD Million)
Figure 23 ECG analysis market 2021 - 2033 (USD Million)
Figure 24 Arrhythmia detection market 2021 - 2033 (USD Million)
Figure 25 Other AI-enabled cardiac diagnostics market 2021 - 2033 (USD Million)
Figure 26 AI neurology & neurological diagnostics market, 2021 - 2033 (USD Million)
Figure 27 Other AI-enabled neurological devices market 2021 - 2033 (USD Million)
Figure 28 Projected increasing population of 65 years and older, 2030-2070 (in %)
Figure 29 AI patient monitoring & physiological monitoring market, 2021 - 2033 (USD Million)
Figure 30 Other AI-enabled medical devices market, 2021 - 2033 (USD Million)
Figure 31 Japan AI-enabled medical devices market: Disease area segment dashboard
Figure 32 Japan AI-enabled medical devices market by disease area: Market share analysis, 2025 & 2033
Figure 33 Oncology market 2021 - 2033 (USD Million)
Figure 34 Cardiovascular diseases market 2021 - 2033 (USD Million)
Figure 35 Neurological disorders market 2021 - 2033 (USD Million)
Figure 36 Gastrointestinal disorders market 2021 - 2033 (USD Million)
Figure 37 Respiratory and pulmonary diseases market 2021 - 2033 (USD Million)
Figure 38 Musculoskeletal and orthopedic conditions market 2021 - 2033 (USD Million)
Figure 39 Other applicable disease areas market 2021 - 2033 (USD Million)
Figure 40 Key company categorization
Figure 41 Company market positioning, 2025
Figure 42 Strategic initiative
Figure 43 Inbound opportunity
Figure 44 Inbound opportunity map - market attractiveness versus ease of entry
Figure 45 Japan local partnership ecosystem for overseas AI-enabled medical device companies